Indonesia’s VC deal numbers are in line to reach a new high this year, boosted by homegrown state-owned enterprises and interest from Asian corporates.
Month: May 2022
Ethical artificial intelligence ecosystem
The demand for ethical artificial intelligence (AI) services (including terms such as “explainable AI” or “responsible AI”) has skyrocketed, in part due to some of the troubling practices employed by large technology companies.
Wearables are the ‘window on the soul’
Sector report: Healthcare and artificial intelligence
Understanding the benefits and threats of sensors
This special quarterly report for both the Global Healthcare Council and Global AI Council picks up how developments in one field are increasingly relevant for others.
Daily Deal Round Up: May 24, 2022
The Global Corporate Venturing deal net rounds up investments from across the corporate innovation ecosystem.
Too many co-investors can be bad for CVC
A University of Groningen study found that CVCs with too many co-investors performed poorly. Getting too close to partners also hurt them.
GCV Symposium: How should CVCs and VCs collaborate?
The partnership between Convivialité Ventures and Cathay Innovation is a good example of a good CVC-VC collaboration. Here’s how it works.
More changes at BP innovation units
The oil and gas supplier’s venturing and accelerator units continue a series of high-profile people moves with the departure of a managing partner.
Daily Deal Round Up: May 23, 2022
The Global Corporate Venturing deal net rounds up investments from across the corporate innovation ecosystem.
How CVC strategies are evolving
Corporates use to struggle to get into syndicates with VCs. Now it is the VCs looking to get into a syndicate with CVCs.
Daily Deal Round Up: May 20, 2022
The Global Corporate Venturing deal net rounds up investments from across the corporate innovation ecosystem.
This is how Chinese VC differs from US and European VC
Financial performance of a sample of Chinese VCs ranged from 14% to 30% per annum, more stable than the range of returns of European and US VC.
GCV Symposium: Healthcare impact funds need to work together
Out of $700bn in impact investing only 7% goes towards healthcare. But Johnson & Johnson is looking at ways to move the needle.
GCV Symposium: Sustainability takes centre stage
Speakers highlighted the growing importance of ESG strategy within CVC investments and how CVCs can help their respective parent firms’ green goals, particularly after COP26.